Danske AI Virksomheder Logo
Virksomheder/AI for life science / biotech information workflows/BioinvestGPT
BioinvestGPT
AI for life science / biotech information workflows
København

BioinvestGPT

AI-powered virtual clinical trial platform predicting drug development outcomes with claimed 96% accuracy.

Status: Redaktionelt indsamletSidst gennemgået: 2. april 2026
Besøg WebsiteOpgradér denne profil

Hvad er BioinvestGPT?

BioinvestGPT is a Copenhagen-based AI company providing virtual clinical trial simulations that predict drug development outcomes with claimed 96% accuracy, serving pharmaceutical companies and healthcare investors to de-risk clinical decisions across candidate nomination, M&A screening, indication expansion, and competitive analysis.

BioinvestGPT provides AI-driven virtual clinical trials using two million human-equivalent virtual patients. The platform predicts clinical trial outcomes for drug candidates across any human disease and any development stage.

Teknologier & Kompetencer

AI for life science / biotech information workflowsvirtual clinical trialspharma AI

Redaktionel metode & kilder

Vi udvælger virksomheder ud fra offentlig dokumentation, virksomhedens egne kanaler, research-noter og manuel redaktionel gennemgang. Oplysninger mærkes som verificeret af virksomheden eller redaktionelt indsamlet.

Profilen er redaktionelt indsamlet på baggrund af offentlige kilder og research-noter.

Produkt

Produktnavn
BioinvestGPT Virtual Clinical Trial Platform

AI-driven virtual clinical trials using 2M human-equivalent virtual patients. Claims 96% ex-ante prediction accuracy validated on 604+ outcomes.

Nøglefunktioner
Virtual clinical trial simulation with 2M+ virtual patients96% ex-ante prediction accuracyData-free approachWhite-box root-cause explanationsHead-to-head drug comparison
Prismodel
No public pricing. B2B enterprise solution.

Målgruppe & Kunder

Målindustrier
Pharmaceutical / BiotechHealthcare investment

Konkurrenter

LokavanteClinical SolutionsJNPMEDIClinithinkSolveBioDatacubed

Ofte stillede spørgsmål om BioinvestGPT

What does BioinvestGPT do?▼
BioinvestGPT provides AI-powered virtual clinical trials using 2 million human-equivalent virtual patients to predict drug development outcomes. It helps pharmaceutical companies and investors make GO/NO-GO decisions on clinical candidates, M&A targets, and indication expansion strategies.
How accurate are BioinvestGPT's predictions?▼
BioinvestGPT claims 96% ex-ante clinical benefit prediction accuracy, validated on 604+ clinical trial outcomes with statistical significance (two-sided p<0.0001). Predictions are delivered with timestamped evidence 100-750+ days before actual clinical readouts.
Who founded BioinvestGPT?▼
BioinvestGPT was founded by Siyi Liu (CEO, known professionally as Idonae Lovetrue) and Zhipan Ren (CTO, known professionally as Bragi Lovetrue). Both are Chinese nationals educated at Stanford Business School, Brown University, NYU, and Carnegie Mellon. They previously founded Demiurge Technologies AG in Switzerland.
Who are BioinvestGPT's clients?▼
BioinvestGPT claims to be trusted by Top 20 Big Pharma companies and Top 5 Institutional Investors, with its technology used to manage over $200 billion in healthcare portfolios. No specific client names are publicly disclosed.
How does BioinvestGPT differ from traditional clinical trial prediction tools?▼
BioinvestGPT uses a data-free approach requiring zero patient input data, instead relying on proprietary virtual patient simulations. It provides white-box root-cause explanations and runs head-to-head virtual clinical trials to compare competing drug candidates.
Is BioinvestGPT funded?▼
No external funding rounds have been publicly disclosed. The company was registered in August 2024 with a capital of 40,000 DKK (approximately €5,400). Tracxn classifies it as Unfunded.
What therapeutic areas does BioinvestGPT cover?▼
BioinvestGPT claims coverage across all major therapeutic areas and drug modalities, including oncology, metabolic disorders, neurology, immunology, cardiovascular diseases, rare diseases, and others. Their public data dashboard shows validated predictions for 492+ drug assets across 267+ sponsors.

Virksomhedsdata

  • LokationKøbenhavn, DK
  • BrancheAI for life science / biotech information workflows
  • GrundlagtIgangværende system data-validering af infomation eller opdatering..
  • StiftereSiyi Liu (CEO, aka Idonae Lovetrue), Zhipan Ren (CTO, aka Bragi Lovetrue)
  • MedarbejdereIgangværende system data-validering af infomation eller opdatering..
  • FundingNo external funding publicly disclosed. Registered capital: 40,000 DKK.
  • PrismodelNo public pricing. B2B enterprise solution.
  • CVR-statusAktiv
  • VerificeretNej
  • ProfilstatusRedaktionelt indsamlet
  • Sidst gennemgåetapril 2026
Links
Website

Brug for hjælp til at finde den rette AI-leverandør?

Vi matcher dig med op til 3 relevante virksomheder — gratis og uforpligtende.